Exosome-like nanoplatform modified with targeting ligand improves anti-cancer and anti-inflammation effects of imperialine.
Lin Q, Qu M, Zhou B, Patra HK, Sun Z, Luo Q, Yang W, Wu Y, Zhang Y, Li L, Deng L, Wang L, Gong T, He Q, Zhang L, Sun X, Zhang Z.
Lin Q, et al.
J Control Release. 2019 Oct;311-312:104-116. doi: 10.1016/j.jconrel.2019.08.037. Epub 2019 Sep 1.
J Control Release. 2019.
PMID: 31484040
Currently, most anti-cancer therapies are still haunted by serious and deleterious adverse effects. Here, we report a highly biocompatible tumor cell-targeting delivery systems utilizing exosome-like vesicles (ELVs) that delivers a low-toxicity anti-cancer agent imperialin …
Currently, most anti-cancer therapies are still haunted by serious and deleterious adverse effects. Here, we report a highly biocompa …